Kevin Chow

Corporate Officer/Principal at ALSP ORCHID ACQUISITION CORPORATION I

54 year

Health Technology

Finance

Consumer Services

Profile

Kevin Chow is the founder of Vitaeris, Inc. founded in 2016, where he held the titles of President, Chief Executive Officer & Director until 2020.
He is currently an Operating Partner at Accelerator Services Corp since 2020, President at Incisive Genetics, Inc. since 2021, and Chief Business Officer at ALSP Orchid Acquisition Corp.
I.
Dr. Chow's former positions include Director-Business Development at Corus Pharma, Inc., Senior Director & Head-Business Development and Director at Lundbeck Seattle BioPharmaceuticals, Inc. from 2009 to 2016.
Dr. Chow's education includes undergraduate, graduate, and doctorate degrees from the University of British Columbia.

Kevin Chow active positions

Companies	Position	Start
ALSP ORCHID ACQUISITION CORPORATION I	Corporate Officer/Principal	-
Incisive Genetics, Inc. Incisive Genetics, Inc. BiotechnologyHealth Technology Incisive Genetics, Inc. is a privately held biotechnology company based in an undisclosed location, established in 2018. The Canadian company has developed a cutting-edge non-viral delivery platform for genetic therapies called Omnia™. This platform enables a one-step encapsulation of the active CRISPR components within lipid nanoparticles. The company's pre-clinical pipeline includes programs addressing neurologic and ocular genetic diseases. The company was founded in 2018 by Blair R. Leavitt, Austin Hill, and Pamela Wagner. Blair R. Leavitt has been the CEO since 2018.	President	2021-06-06
Accelerator Services Corp Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington.	Private Equity Investor	2020-08-31

All active positions of Kevin Chow

Former positions of Kevin Chow

Companies	Position	End
Vitaeris, Inc. Vitaeris, Inc. BiotechnologyHealth Technology Vitaeris, Inc. develops new treatment options for chronic inflammatory diseases. The company was founded by Kevin Chow, Patrick A. Robinson and Noel F. Hall in 2016 and is headquartered in Vancouver, Canada.	Founder	2020-07-31
ALDER BIOPHARMACEUTICALS, INC.	Director/Board Member	2016-07-29
ALDER BIOPHARMACEUTICALS, INC.	Director/Board Member	2016-05-31
Corus Pharma, Inc. Corus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Corus Pharma, Inc. develops drugs to treat needs in infectious diseases and respiratory areas. The firm's core competencies reside in the identification of drugs, rapid clinical development, and FDA approval of its products. The firm was founded in January 2001 by A. Bruce Montgomery and is headquartered in Seattle, WA.	Corporate Officer/Principal	-

See the detail of Kevin Chow's experience

Training of Kevin Chow

University of British Columbia

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Kevin Chow's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	6
Corus Pharma, Inc. Corus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Corus Pharma, Inc. develops drugs to treat needs in infectious diseases and respiratory areas. The firm's core competencies reside in the identification of drugs, rapid clinical development, and FDA approval of its products. The firm was founded in January 2001 by A. Bruce Montgomery and is headquartered in Seattle, WA.	Health Technology
Lundbeck Seattle BioPharmaceuticals, Inc. Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lundbeck Seattle BioPharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on transforming the migraine treatment paradigm through the discovery, development and commercialization of novel therapeutic antibodies. Its product includes Eptinezumab, is an investigational monoclonal antibody (mAb) that inhibits calcitonin gene-related peptide (CGRP) and is currently in late-stage clinical development for the prevention of migraine. The company was founded by Randall C. Schatzman, Mark J. Litton, and John A. Latham in January 2004 and is headquartered in Bothell, WA.	Health Technology
Accelerator Services Corp Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington.	Finance
Vitaeris, Inc. Vitaeris, Inc. BiotechnologyHealth Technology Vitaeris, Inc. develops new treatment options for chronic inflammatory diseases. The company was founded by Kevin Chow, Patrick A. Robinson and Noel F. Hall in 2016 and is headquartered in Vancouver, Canada.	Health Technology
Incisive Genetics, Inc. Incisive Genetics, Inc. BiotechnologyHealth Technology Incisive Genetics, Inc. is a privately held biotechnology company based in an undisclosed location, established in 2018. The Canadian company has developed a cutting-edge non-viral delivery platform for genetic therapies called Omnia™. This platform enables a one-step encapsulation of the active CRISPR components within lipid nanoparticles. The company's pre-clinical pipeline includes programs addressing neurologic and ocular genetic diseases. The company was founded in 2018 by Blair R. Leavitt, Austin Hill, and Pamela Wagner. Blair R. Leavitt has been the CEO since 2018.	Health Technology
ALSP Orchid Acquisition Corp. I ALSP Orchid Acquisition Corp. I Financial ConglomeratesFinance ALSP Orchid Acquisition Corp. I is a blank check company. It was formed for the purpose of acquiring, through a merger, capital stock exchange, asset acquisition, stock purchase or other similar business combination, one or more operating businesses. The company was founded on August 31, 2021 and is headquartered in Seattle, WA.	Finance

See company connections